Royce & Associates LP Agenus Inc Transaction History

Royce & Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 23, 2023	BUY	$2.02 - $3.25 $34,111 - $54,882	16,887 New	16,887 $40,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $4,547 - $7,315	2,251 Added 15.38%	16,887 $41,000
Q3 2022 Nov 03, 2022	SELL	$1.96 - $3.14 $18,255 - $29,245	-9,314 Reduced 38.89%	14,636 $30,000
Q2 2022 Aug 04, 2022	BUY	$1.3 - $2.64 $31,135 - $63,228	23,950 New	23,950 $46,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.